JP2021531834A5 - - Google Patents
Info
- Publication number
- JP2021531834A5 JP2021531834A5 JP2021529507A JP2021529507A JP2021531834A5 JP 2021531834 A5 JP2021531834 A5 JP 2021531834A5 JP 2021529507 A JP2021529507 A JP 2021529507A JP 2021529507 A JP2021529507 A JP 2021529507A JP 2021531834 A5 JP2021531834 A5 JP 2021531834A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- amino acid
- seq
- chain
- exon
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810854117.4A CN110776562B (zh) | 2018-07-30 | 2018-07-30 | 一种识别afp抗原的t细胞受体 |
| CN201810854117.4 | 2018-07-30 | ||
| PCT/CN2019/098245 WO2020024915A1 (zh) | 2018-07-30 | 2019-07-29 | 一种识别afp抗原的t细胞受体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021531834A JP2021531834A (ja) | 2021-11-25 |
| JPWO2020024915A5 JPWO2020024915A5 (https=) | 2022-08-04 |
| JP2021531834A5 true JP2021531834A5 (https=) | 2022-08-04 |
| JP7429455B2 JP7429455B2 (ja) | 2024-02-08 |
Family
ID=69232312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021529507A Active JP7429455B2 (ja) | 2018-07-30 | 2019-07-29 | Ａｆｐ抗原を識別するｔ細胞受容体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12152065B2 (https=) |
| EP (1) | EP3831845A4 (https=) |
| JP (1) | JP7429455B2 (https=) |
| CN (1) | CN110776562B (https=) |
| CA (1) | CA3108466A1 (https=) |
| WO (1) | WO2020024915A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111662374B (zh) * | 2019-03-08 | 2023-01-24 | 香雪生命科学技术（广东）有限公司 | 一种识别afp抗原的高亲和力tcr |
| AU2021219334A1 (en) * | 2020-02-14 | 2022-09-01 | Adaptimmune Limited | Method of treatment of cancer or tumour |
| CN113321727B (zh) * | 2020-02-28 | 2024-04-09 | 香雪生命科学技术（广东）有限公司 | 一种识别afp抗原短肽的t细胞受体及其编码序列 |
| CN113493505A (zh) * | 2020-03-20 | 2021-10-12 | 香雪生命科学技术（广东）有限公司 | 识别afp抗原的高亲和力tcr |
| WO2022022696A1 (zh) * | 2020-07-30 | 2022-02-03 | 香雪生命科学技术（广东）有限公司 | 一种识别afp的高亲和力tcr |
| US20240279318A1 (en) * | 2021-05-31 | 2024-08-22 | Nanjing Legend Biotech Co., Ltd. | Antibodies targeting afp peptide/mhc complexes and uses thereof |
| JP7210677B1 (ja) * | 2021-10-20 | 2023-01-23 | デンカ株式会社 | 非水硬性セメント組成物及びセメント系材料 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2645256C2 (ru) | 2013-06-26 | 2018-02-19 | Гуандун Сянсюэ Лайф Сайенсис, Лтд. | Высокостабильный т-клеточный рецептор и способ его получения и применения |
| GB201313377D0 (en) | 2013-07-26 | 2013-09-11 | Adaptimmune Ltd | T cell receptors |
| CN104087592B (zh) * | 2014-05-13 | 2016-01-27 | 天津医科大学总医院 | Afp158-166特异性tcr基因及其转基因t细胞及体外增殖方法及用途 |
| AU2016243026B2 (en) * | 2015-04-03 | 2022-03-31 | Eureka Therapeutics, Inc. | Constructs targeting AFP peptide/MHC complexes and uses thereof |
| CN107847570A (zh) * | 2015-05-08 | 2018-03-27 | 优瑞科生物技术公司 | 靶向hpv16‑e7肽/mhc复合体的构建体及其用途 |
| CN107922471A (zh) * | 2015-06-24 | 2018-04-17 | 优瑞科生物技术公司 | 靶向ny‑eso‑1肽/mhc复合物的构建体及其用途 |
| GB201520575D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| CN105524884A (zh) * | 2016-02-29 | 2016-04-27 | 时宏珍 | Hla-a0201限制性抗afp抗原特异性ctl的制备方法 |
| SG11201909751TA (en) * | 2017-05-12 | 2019-11-28 | Augusta University Research Institute Inc | Human alpha fetoprotein-specific t cell receptors and uses thereof |
| CN111662374B (zh) * | 2019-03-08 | 2023-01-24 | 香雪生命科学技术（广东）有限公司 | 一种识别afp抗原的高亲和力tcr |
-
2018
- 2018-07-30 CN CN201810854117.4A patent/CN110776562B/zh active Active
-
2019
- 2019-07-29 EP EP19845331.8A patent/EP3831845A4/en not_active Withdrawn
- 2019-07-29 WO PCT/CN2019/098245 patent/WO2020024915A1/zh not_active Ceased
- 2019-07-29 JP JP2021529507A patent/JP7429455B2/ja active Active
- 2019-07-29 US US17/264,649 patent/US12152065B2/en active Active
- 2019-07-29 CA CA3108466A patent/CA3108466A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502056A5 (https=) | ||
| JP2021531834A5 (https=) | ||
| JPWO2020063488A5 (https=) | ||
| HRP20230542T1 (hr) | T stanični receptori | |
| JP2021520198A5 (https=) | ||
| JP2018504092A5 (https=) | ||
| RU2016101711A (ru) | Высокостабильный т-клеточный рецептор и способ его получения и применения | |
| HRP20220865T1 (hr) | T stanični receptori | |
| JP2023139070A5 (https=) | ||
| HRP20221021T1 (hr) | T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02 | |
| BR112020000769A2 (pt) | anticorpo de dupla especificidade, moléculas polipeptídicas, ácido nucleico, célula hospedeira, composição farmacêutica e método de tratamento de uma doença ou condição | |
| JP2021511826A5 (https=) | ||
| JP2019137675A5 (https=) | ||
| JP2021533779A (ja) | 操作された二重特異性タンパク質 | |
| JP2017527272A5 (https=) | ||
| JP2020501550A5 (https=) | ||
| CN113195530B (zh) | 抗体融合蛋白、制备方法及其应用 | |
| TW201245228A (en) | Fusion proteins for HIV therapy | |
| JPWO2019195486A5 (https=) | ||
| WO2019196309A1 (zh) | 抗pd-l1抗体及其用途 | |
| CN106336457B (zh) | 识别mage‑a3抗原短肽的t细胞受体 | |
| JP2018522061A5 (https=) | ||
| JP2022502078A5 (https=) | ||
| KR20220012227A (ko) | Clec9a-기반 키메라 단백질 복합체 | |
| JP2017524675A5 (https=) |